02.02.2017 21:46:00
|
DaVita Recognized Among 2017 Training Top 125
DENVER, Feb. 2, 2017 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced the company was recognized among Training magazine's Top 125 for its exceptional training and leadership development programs. The company has appeared on the list for 13 years in a row.
"We focus on whole-person growth and learning that empowers our teammates to take an active role in their personal and professional journeys," said Dave Hoerman, chief wisdom officer at DaVita. "Our goal is to help teammates lead more healthy and fulfilled lives, which translates into improved quality care for our patients."
DaVita offers a variety of in-person and online courses and programs to help create a special place for its teammates. For example, the company designed the DSS Leadership program to find, nurture and help teammates grow who have potential for management roles and the desire to develop as leaders. The six-month course teaches the fundamentals of leadership through lectures, self-assessment and reading assignments.
DaVita has also been named a finalist by Chief Learning Officer magazine in its LearningElite program, which recognizes organizations for their learning and development strategies that deliver business results.
Explore how DaVita invests in its teammates' professional and personal growth at DaVita.com/CSR.
About DaVita Inc.
DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners, a DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of September 30, 2016, DaVita Kidney Care operated or provided administrative services at 2,318 outpatient dialysis centers located in the United States serving approximately 186,000 patients. The company also operated 139 outpatient dialysis centers located in 11 countries outside the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks in California, Nevada, New Mexico, Florida, Colorado and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of September 30, 2016 HealthCare Partners provided integrated care management for approximately 750,000 patients. For more information, please visit DaVita.com/about.
Contact Information
Media:
Caitlyn Shuket
(303) 876-7547
Caitlyn.Shuket@davita.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/davita-recognized-among-2017-training-top-125-300401564.html
SOURCE DaVita Inc.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DaVita HealthCare Partners Incmehr Nachrichten
14.02.25 |
NYSE-Handel: S&P 500 klettert (finanzen.at) | |
14.02.25 |
S&P 500-Handel aktuell: S&P 500 in der Gewinnzone (finanzen.at) | |
14.02.25 |
Zuversicht in New York: S&P 500 beginnt Sitzung mit Gewinnen (finanzen.at) | |
14.02.25 |
AKTIE IM FOKUS 2: FMC schwach - Davita überzeugt nicht, Hohe Sterblichkeit (dpa-AFX) | |
12.02.25 |
Ausblick: DaVita HealthCare Partners legt Quartalsergebnis vor (finanzen.net) | |
10.02.25 |
S&P 500-Papier DaVita HealthCare Partners-Aktie: So viel Gewinn hätte eine DaVita HealthCare Partners-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
03.02.25 |
S&P 500-Papier DaVita HealthCare Partners-Aktie: So viel Gewinn hätte ein Investment in DaVita HealthCare Partners von vor einem Jahr abgeworfen (finanzen.at) | |
27.01.25 |
S&P 500-Papier DaVita HealthCare Partners-Aktie: So viel hätten Anleger an einem DaVita HealthCare Partners-Investment von vor 10 Jahren verdient (finanzen.at) |
Analysen zu DaVita HealthCare Partners Incmehr Analysen
Aktien in diesem Artikel
DaVita HealthCare Partners Inc | 148,30 | -12,46% |
|